Literature DB >> 19471638

Failure of screening or failure to screen? The screening behavior of patients with colorectal cancer in the Leipzig area.

Konrad Schoppmeyer1, Henning Spieker, Joachim Mössner.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is the second most common cancer-related cause of death in Germany. Screening for colorectal cancer is effective and is covered by statutory health insurance in Germany.
METHODS: The authors studied the screening behavior of patients with CRC in the Leipzig area in the 10 years before their diagnosis. The patients were asked to fill out a standardized questionnaire, and their primary care physicians were questioned, in order to determine what screening measures had been performed and why none had been performed in some cases.
RESULTS: 212 patients with CRC were studied. In 175 (83%), cancer had been diagnosed after the appearance of symptoms ("symptomatic group"); in 37 (17%), it had been detected by screening ("screening group"). 51% of the overall patient group had undergone CRC screening in the 10 years before their diagnosis. A test of the stool for occult blood was the most common screening method but was generally not performed in conformity with guidelines. 25 patients (12%) had undergone a screening colonoscopy in the 10 years before their diagnosis; of these 25, 20 had undergone a screening colonoscopy in the 5 years before their diagnosis. The main reason why screening was not performed was ignorance of its availability.
CONCLUSIONS: This retrospective study revealed that, of 212 patients with CRC, most had not previously undergone CRC screening in conformity with guidelines. Better patient education by physicians may improve the effectiveness of screening. Appropriate screening measures include fecal occult blood testing and colonoscopy in conformity with guidelines.

Entities:  

Keywords:  colonoscopy; colorectal cancer; health services research; screening test; stool test

Mesh:

Year:  2009        PMID: 19471638      PMCID: PMC2680578          DOI: 10.3238/arztebl.2009.0195

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  20 in total

1.  Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence.

Authors:  F Citarda; G Tomaselli; R Capocaccia; S Barcherini; M Crespi
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence.

Authors:  Polly A Newcomb; Barry E Storer; Libby M Morimoto; Allyson Templeton; John D Potter
Journal:  J Natl Cancer Inst       Date:  2003-04-16       Impact factor: 13.506

3.  [S3-Guidelines Conference "Colorectal Carcinoma" 2004].

Authors:  W Schmiegel; C Pox; G Adler; W Fleig; U R Fölsch; P Frühmorgen; U Graeven; W Hohenberger; A Holstege; T Junginger; T Kühlbacher; R Porschen; P Propping; J F Riemann; R Sauer; T Sauerbruch; H J Schmoll; M Zeitz; H K Selbmann
Journal:  Z Gastroenterol       Date:  2004-10       Impact factor: 2.000

4.  Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists.

Authors:  A Sieg; U Hachmoeller-Eisenbach; T Eisenbach
Journal:  Gastrointest Endosc       Date:  2001-05       Impact factor: 9.427

Review 5.  Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.

Authors:  Paul Hewitson; Paul Glasziou; Eila Watson; Bernie Towler; Les Irwig
Journal:  Am J Gastroenterol       Date:  2008-05-13       Impact factor: 10.864

6.  Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice.

Authors:  Judith F Collins; David A Lieberman; Theodore E Durbin; David G Weiss
Journal:  Ann Intern Med       Date:  2005-01-18       Impact factor: 25.391

7.  A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy.

Authors:  Gavin C Harewood; Maurits J Wiersema; L Joseph Melton
Journal:  Am J Gastroenterol       Date:  2002-12       Impact factor: 10.864

8.  A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.

Authors:  J V Selby; G D Friedman; C P Quesenberry; N S Weiss
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

9.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

10.  Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing.

Authors:  J E Verne; R Aubrey; S B Love; I C Talbot; J M Northover
Journal:  BMJ       Date:  1998-07-18
View more
  3 in total

1.  Intestinal cancer despite screening: negative experience from Leipzig.

Authors:  Lutz Altenhofen
Journal:  Dtsch Arztebl Int       Date:  2009-03-20       Impact factor: 5.594

2.  Why so late?!--delay in treatment of colorectal cancer is socially determined.

Authors:  Mike Ralf Langenbach; Stefan Sauerland; Karl-Wilhelm Kröbel; Hubert Zirngibl
Journal:  Langenbecks Arch Surg       Date:  2010-06-27       Impact factor: 3.445

3.  Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany.

Authors:  Andreas Adler; Sebastian Geiger; Anne Keil; Harald Bias; Philipp Schatz; Theo deVos; Jens Dhein; Mathias Zimmermann; Rudolf Tauber; Bertram Wiedenmann
Journal:  BMC Gastroenterol       Date:  2014-10-17       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.